By harnessing the power of open source artificial intelligence (AI), researchers have devised coded models capable of rapidly identifying potential therapeutic compounds. This approach has the capability to expedite the identification of promising drug candidates for a wide range of diseases. In the study, published in the open access journal Pharmaceuticals MDPI, researchers from Chapman University created an automated GenAI methodology, fittingly called ‘drugAI’. The aim of this approach is to